Copyright Reports & Markets. All rights reserved.

Global Continuous Glucose Monitoring Systems Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Continuous Glucose Monitoring Systems Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Wearable
    • 1.3.3 Non-wearable
  • 1.4 Market Analysis by End Users
    • 1.4.1 Overview: Global Continuous Glucose Monitoring Systems Consumption Value by End Users: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Home Care
    • 1.4.4 Other
  • 1.5 Global Continuous Glucose Monitoring Systems Market Size & Forecast
    • 1.5.1 Global Continuous Glucose Monitoring Systems Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Continuous Glucose Monitoring Systems Sales Quantity (2021-2032)
    • 1.5.3 Global Continuous Glucose Monitoring Systems Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Continuous Glucose Monitoring Systems Product and Services
    • 2.1.4 Abbott Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 DexCom
    • 2.2.1 DexCom Details
    • 2.2.2 DexCom Major Business
    • 2.2.3 DexCom Continuous Glucose Monitoring Systems Product and Services
    • 2.2.4 DexCom Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 DexCom Recent Developments/Updates
  • 2.3 Medtronic
    • 2.3.1 Medtronic Details
    • 2.3.2 Medtronic Major Business
    • 2.3.3 Medtronic Continuous Glucose Monitoring Systems Product and Services
    • 2.3.4 Medtronic Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Medtronic Recent Developments/Updates
  • 2.4 Senseonics Holdings
    • 2.4.1 Senseonics Holdings Details
    • 2.4.2 Senseonics Holdings Major Business
    • 2.4.3 Senseonics Holdings Continuous Glucose Monitoring Systems Product and Services
    • 2.4.4 Senseonics Holdings Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Senseonics Holdings Recent Developments/Updates
  • 2.5 Cnoga Medical
    • 2.5.1 Cnoga Medical Details
    • 2.5.2 Cnoga Medical Major Business
    • 2.5.3 Cnoga Medical Continuous Glucose Monitoring Systems Product and Services
    • 2.5.4 Cnoga Medical Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cnoga Medical Recent Developments/Updates
  • 2.6 Meiqi Medical
    • 2.6.1 Meiqi Medical Details
    • 2.6.2 Meiqi Medical Major Business
    • 2.6.3 Meiqi Medical Continuous Glucose Monitoring Systems Product and Services
    • 2.6.4 Meiqi Medical Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Meiqi Medical Recent Developments/Updates
  • 2.7 Medtrum Technologies
    • 2.7.1 Medtrum Technologies Details
    • 2.7.2 Medtrum Technologies Major Business
    • 2.7.3 Medtrum Technologies Continuous Glucose Monitoring Systems Product and Services
    • 2.7.4 Medtrum Technologies Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Medtrum Technologies Recent Developments/Updates
  • 2.8 MicroTech Medical
    • 2.8.1 MicroTech Medical Details
    • 2.8.2 MicroTech Medical Major Business
    • 2.8.3 MicroTech Medical Continuous Glucose Monitoring Systems Product and Services
    • 2.8.4 MicroTech Medical Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 MicroTech Medical Recent Developments/Updates
  • 2.9 POCTech
    • 2.9.1 POCTech Details
    • 2.9.2 POCTech Major Business
    • 2.9.3 POCTech Continuous Glucose Monitoring Systems Product and Services
    • 2.9.4 POCTech Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 POCTech Recent Developments/Updates
  • 2.10 SIBIONICS
    • 2.10.1 SIBIONICS Details
    • 2.10.2 SIBIONICS Major Business
    • 2.10.3 SIBIONICS Continuous Glucose Monitoring Systems Product and Services
    • 2.10.4 SIBIONICS Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 SIBIONICS Recent Developments/Updates
  • 2.11 GHA Life
    • 2.11.1 GHA Life Details
    • 2.11.2 GHA Life Major Business
    • 2.11.3 GHA Life Continuous Glucose Monitoring Systems Product and Services
    • 2.11.4 GHA Life Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 GHA Life Recent Developments/Updates
  • 2.12 Infinovo Medical
    • 2.12.1 Infinovo Medical Details
    • 2.12.2 Infinovo Medical Major Business
    • 2.12.3 Infinovo Medical Continuous Glucose Monitoring Systems Product and Services
    • 2.12.4 Infinovo Medical Continuous Glucose Monitoring Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Infinovo Medical Recent Developments/Updates

3 Competitive Environment: Continuous Glucose Monitoring Systems by Manufacturer

  • 3.1 Global Continuous Glucose Monitoring Systems Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Continuous Glucose Monitoring Systems Revenue by Manufacturer (2021-2026)
  • 3.3 Global Continuous Glucose Monitoring Systems Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Continuous Glucose Monitoring Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Continuous Glucose Monitoring Systems Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Continuous Glucose Monitoring Systems Manufacturer Market Share in 2025
  • 3.5 Continuous Glucose Monitoring Systems Market: Overall Company Footprint Analysis
    • 3.5.1 Continuous Glucose Monitoring Systems Market: Region Footprint
    • 3.5.2 Continuous Glucose Monitoring Systems Market: Company Product Type Footprint
    • 3.5.3 Continuous Glucose Monitoring Systems Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Continuous Glucose Monitoring Systems Market Size by Region
    • 4.1.1 Global Continuous Glucose Monitoring Systems Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Continuous Glucose Monitoring Systems Consumption Value by Region (2021-2032)
    • 4.1.3 Global Continuous Glucose Monitoring Systems Average Price by Region (2021-2032)
  • 4.2 North America Continuous Glucose Monitoring Systems Consumption Value (2021-2032)
  • 4.3 Europe Continuous Glucose Monitoring Systems Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Continuous Glucose Monitoring Systems Consumption Value (2021-2032)
  • 4.5 South America Continuous Glucose Monitoring Systems Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Continuous Glucose Monitoring Systems Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Continuous Glucose Monitoring Systems Sales Quantity by Type (2021-2032)
  • 5.2 Global Continuous Glucose Monitoring Systems Consumption Value by Type (2021-2032)
  • 5.3 Global Continuous Glucose Monitoring Systems Average Price by Type (2021-2032)

6 Market Segment by End Users

  • 6.1 Global Continuous Glucose Monitoring Systems Sales Quantity by End Users (2021-2032)
  • 6.2 Global Continuous Glucose Monitoring Systems Consumption Value by End Users (2021-2032)
  • 6.3 Global Continuous Glucose Monitoring Systems Average Price by End Users (2021-2032)

7 North America

  • 7.1 North America Continuous Glucose Monitoring Systems Sales Quantity by Type (2021-2032)
  • 7.2 North America Continuous Glucose Monitoring Systems Sales Quantity by End Users (2021-2032)
  • 7.3 North America Continuous Glucose Monitoring Systems Market Size by Country
    • 7.3.1 North America Continuous Glucose Monitoring Systems Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Continuous Glucose Monitoring Systems Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Continuous Glucose Monitoring Systems Sales Quantity by Type (2021-2032)
  • 8.2 Europe Continuous Glucose Monitoring Systems Sales Quantity by End Users (2021-2032)
  • 8.3 Europe Continuous Glucose Monitoring Systems Market Size by Country
    • 8.3.1 Europe Continuous Glucose Monitoring Systems Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Continuous Glucose Monitoring Systems Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Continuous Glucose Monitoring Systems Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Continuous Glucose Monitoring Systems Sales Quantity by End Users (2021-2032)
  • 9.3 Asia-Pacific Continuous Glucose Monitoring Systems Market Size by Region
    • 9.3.1 Asia-Pacific Continuous Glucose Monitoring Systems Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Continuous Glucose Monitoring Systems Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Continuous Glucose Monitoring Systems Sales Quantity by Type (2021-2032)
  • 10.2 South America Continuous Glucose Monitoring Systems Sales Quantity by End Users (2021-2032)
  • 10.3 South America Continuous Glucose Monitoring Systems Market Size by Country
    • 10.3.1 South America Continuous Glucose Monitoring Systems Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Continuous Glucose Monitoring Systems Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Continuous Glucose Monitoring Systems Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Continuous Glucose Monitoring Systems Sales Quantity by End Users (2021-2032)
  • 11.3 Middle East & Africa Continuous Glucose Monitoring Systems Market Size by Country
    • 11.3.1 Middle East & Africa Continuous Glucose Monitoring Systems Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Continuous Glucose Monitoring Systems Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Continuous Glucose Monitoring Systems Market Drivers
  • 12.2 Continuous Glucose Monitoring Systems Market Restraints
  • 12.3 Continuous Glucose Monitoring Systems Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Continuous Glucose Monitoring Systems and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Continuous Glucose Monitoring Systems
  • 13.3 Continuous Glucose Monitoring Systems Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Continuous Glucose Monitoring Systems Typical Distributors
  • 14.3 Continuous Glucose Monitoring Systems Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Continuous Glucose Monitoring Systems market size was valued at US$ 14700 million in 2025 and is forecast to a readjusted size of US$ 35840 million by 2032 with a CAGR of 13.7% during review period.
    Continuous Glucose Monitoring Systems (CGM) are advanced medical devices designed to continuously track glucose levels in the interstitial fluid of diabetic patients. The system typically consists of a small sensor inserted under the skin, which transmits glucose readings wirelessly to a receiver, smartphone, or insulin pump. Unlike traditional fingerstick testing, CGM offers real-time glucose trends, alerts for hypo- or hyperglycemia, and comprehensive data for personalized diabetes management. As sensor technology, wireless communication, and AI integration advance, CGM is increasingly positioned not only for diabetes care but also as a core component in broader digital health, sports medicine, and preventive care systems. In 2024, global Continuous Glucose Monitoring Systems production reached approximately 289057 k units, with an average global market price of around US$ 42.4/unit.
    With the global diabetes population continuously expanding, CGM systems are gaining widespread adoption as effective tools for precise and intelligent glucose monitoring. In developed markets like the U.S. and Europe, expanding insurance reimbursement policies are significantly boosting CGM penetration among both Type 1 and Type 2 diabetes patients. Meanwhile, developing countries such as China and India, facing surging diabetes incidence, are experiencing rapid CGM market growth supported by digital healthcare reform and public health initiatives. Leading companies including Dexcom, Abbott, and Medtronic continue to innovate through features like calibration-free sensors, improved wearability, and seamless AI integration, driving user adherence and expanding clinical applications. Despite the strong market outlook, several barriers remain. High device costs pose affordability issues, particularly in markets without sufficient insurance coverage. Additionally, stringent requirements on accuracy, safety, and reliability increase R&D and manufacturing costs. Concerns around data privacy, system interoperability, and patient adoption persist, especially in regions where CGM’s clinical value is still under debate. Limited insurance reimbursement in some markets further restrains uptake. The market is also highly consolidated, dominated by a few global players with significant patent and brand advantages, creating high entry barriers for new competitors. There is a growing shift from hospital-centered care to patient-centric chronic disease management, driving demand for CGM systems in home settings and personal health applications. Home monitoring, telemedicine, and chronic care platforms are pushing CGM devices to integrate more deeply with mobile apps, wearables, and AI-based health services. New user groups such as fitness enthusiasts and women with gestational diabetes are emerging. Companies are evolving from traditional device suppliers into digital health ecosystem providers, building closed-loop solutions that combine hardware, platforms, and data analytics, and positioning CGM as a central component of proactive health management.
    This report is a detailed and comprehensive analysis for global Continuous Glucose Monitoring Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Continuous Glucose Monitoring Systems market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Continuous Glucose Monitoring Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Continuous Glucose Monitoring Systems market size and forecasts, by Type and by End Users, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Continuous Glucose Monitoring Systems market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Continuous Glucose Monitoring Systems
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Continuous Glucose Monitoring Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, DexCom, Medtronic, Senseonics Holdings, Cnoga Medical, Meiqi Medical, Medtrum Technologies, MicroTech Medical, POCTech, SIBIONICS, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Continuous Glucose Monitoring Systems market is split by Type and by End Users. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Wearable
    Non-wearable
    Market segment by End Users
    Hospital
    Home Care
    Other
    Major players covered
    Abbott
    DexCom
    Medtronic
    Senseonics Holdings
    Cnoga Medical
    Meiqi Medical
    Medtrum Technologies
    MicroTech Medical
    POCTech
    SIBIONICS
    GHA Life
    Infinovo Medical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Continuous Glucose Monitoring Systems product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Continuous Glucose Monitoring Systems, with price, sales quantity, revenue, and global market share of Continuous Glucose Monitoring Systems from 2021 to 2026.
    Chapter 3, the Continuous Glucose Monitoring Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Continuous Glucose Monitoring Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by End Users, with sales market share and growth rate by Type, by End Users, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Continuous Glucose Monitoring Systems market forecast, by regions, by Type, and by End Users, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Continuous Glucose Monitoring Systems.
    Chapter 14 and 15, to describe Continuous Glucose Monitoring Systems sales channel, distributors, customers, research findings and conclusion.

    Buy now